College of Pharmacy
In this section
Podcast Archive
HelixTalk #178 - Law & Order: Pharmacy Edition. A Concise Review of High-Yield Pharmacy Law Topics for the MPJE
Date posted: February 13, 2024, 6:00 am
In this episode, we speak with Janeen Winnike, the Associate Dean for Student Affairs at Rosalind Franklin and a co-course director for the Pharmacy Law course at the university. We review some of the key points regarding federal and Illinois pharmacy law – a must-listen especially for graduates preparing for their MPJE exam after graduation!
HelixTalk #177 - The Antidote Arsenal: Exploring the Emergency Toolbox for Anticoagulant Reversals
Date posted: January 23, 2024, 6:00 am
In this episode, we review evidence-based guidelines for the emergency reversal of warfarin, dabigatran, and the oral Xa inhibitors (apixaban, edoxaban, and rivaroxaban).
HelixTalk #176 - Hormonal Harmony: A Pharmacist’s Guide to Hormonal Contraceptives (Part 2)
Date posted: January 2, 2024, 6:00 am
In this two part episode, we review some of the most important clinical pearls in the pharmacotherapy and practice aspects of hormonal contraceptives with a brief focus on the very first FDA approved OTC hormonal contraceptive product (Opill).
HelixTalk #175 - Hormonal Harmony: A Pharmacist’s Guide to Hormonal Contraceptives (Part 1)
Date posted: December 13, 2023, 11:00 am
In this two part episode, we review some of the most important clinical pearls in the pharmacotherapy and practice aspects of hormonal contraceptives with a brief focus on the very first FDA approved OTC hormonal contraceptive product (Opill).
HelixTalk #174 - Finding Your Mount Rushmore: The Journey of an Industry Pharmacist
Date posted: December 4, 2023, 1:00 pm
In this episode, we interview Scott Glosner, PharmD, MPH, BCPS about his extensive experience working at Pfizer in medical outcomes and as a field medical director. Dr. Glosner will share his career journey from a clinical pharmacist transitioning into the pharmaceutical industry in the late 1990s and what current pharmacists and students should know about a job in a pharmaceutical company.
Dr. Scott Glosner is an employee of Pfizer and that the views expressed by him may not represent the views of Pfizer.
HelixTalk #173 - Balancing Access and Safety: The FDA's Prescription Drug Risk Mitigation Strategy (REMS)
Date posted: October 31, 2023, 6:00 am
In this episode, we will discuss the definition of REMS (Risk Evaluation and Mitigation Strategies), why they exist, the role of FDA in administering REMS, types and examples of REMS, and how they impact pharmacy practice.
HelixTalk #172 - Battle of the Clot Busters: Alteplase vs. Tenecteplase for Acute Ischemic Stroke
Date posted: October 10, 2023, 6:00 am
In this episode, we review the role and indications of thrombolytics in acute ischemic stroke. The efficacy, safety, administration considerations, and cost between alteplase and tenecteplase are compared and contrasted.
HelixTalk #171 - Two Vax’s and a MAB: What’s New in RSV Prevention
Date posted: September 19, 2023, 6:00 am
In this episode, we briefly review RSV (respiratory syncytial virus) infections and focus on new data supporting the use of two different RSV vaccines (Abrysvo and Arvexy) in preventing RSV infections in older adults and in pregnant women.
HelixTalk #170 - Hope and Healing: Overcoming Opioid Use Disorder Through Evidence-Based Therapies
Date posted: August 29, 2023, 6:00 am
In this episode, together with our faculty colleague, Dr. Roberta Dume, PharmD, BCPP, we discuss the pharmacologic options and evidence for the treatment of opioid use disorder (OUD) and how pharmacists play a vital role in assisting patients suffering from opioid use disorder.
HelixTalk #169 - Introducing HelixTalk’s 2023 Drug Superlative Awards!
Date posted: August 8, 2023, 6:00 am
In this episode, we announce the second iteration of the HelixTalk Drug Superlative Awards -- awards given to medications on the market that are outstanding or notorious. In announcing these completely fictitious awards, we review key clinical pearls and pitfalls that every clinician should be aware of with these notable medications.